Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD
Clinical trial NCT00577837 · COMPLETED
Trial details
- NCT number
- NCT00577837
- Sponsor
- Warner Chilcott
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2005-06-01
- Enrollment
- 370
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.